337 related articles for article (PubMed ID: 20705491)
1. The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity.
Tavares RM; Turer EE; Liu CL; Advincula R; Scapini P; Rhee L; Barrera J; Lowell CA; Utz PJ; Malynn BA; Ma A
Immunity; 2010 Aug; 33(2):181-91. PubMed ID: 20705491
[TBL] [Abstract][Full Text] [Related]
2. B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice.
Chu Y; Vahl JC; Kumar D; Heger K; Bertossi A; Wójtowicz E; Soberon V; Schenten D; Mack B; Reutelshöfer M; Beyaert R; Amann K; van Loo G; Schmidt-Supprian M
Blood; 2011 Feb; 117(7):2227-36. PubMed ID: 21088135
[TBL] [Abstract][Full Text] [Related]
3. A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies.
Hövelmeyer N; Reissig S; Xuan NT; Adams-Quack P; Lukas D; Nikolaev A; Schlüter D; Waisman A
Eur J Immunol; 2011 Mar; 41(3):595-601. PubMed ID: 21341261
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity.
Kool M; van Loo G; Waelput W; De Prijck S; Muskens F; Sze M; van Praet J; Branco-Madeira F; Janssens S; Reizis B; Elewaut D; Beyaert R; Hammad H; Lambrecht BN
Immunity; 2011 Jul; 35(1):82-96. PubMed ID: 21723156
[TBL] [Abstract][Full Text] [Related]
5. Dimerization and ubiquitin mediated recruitment of A20, a complex deubiquitinating enzyme.
Lu TT; Onizawa M; Hammer GE; Turer EE; Yin Q; Damko E; Agelidis A; Shifrin N; Advincula R; Barrera J; Malynn BA; Wu H; Ma A
Immunity; 2013 May; 38(5):896-905. PubMed ID: 23602765
[TBL] [Abstract][Full Text] [Related]
6. The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells.
Giordano M; Roncagalli R; Bourdely P; Chasson L; Buferne M; Yamasaki S; Beyaert R; van Loo G; Auphan-Anezin N; Schmitt-Verhulst AM; Verdeil G
Proc Natl Acad Sci U S A; 2014 Jul; 111(30):11115-20. PubMed ID: 25024217
[TBL] [Abstract][Full Text] [Related]
7. A20 suppresses vascular inflammation by recruiting proinflammatory signaling molecules to intracellular aggresomes.
Enesa K; Moll HP; Luong L; Ferran C; Evans PC
FASEB J; 2015 May; 29(5):1869-78. PubMed ID: 25667218
[TBL] [Abstract][Full Text] [Related]
8. Frequent inactivation of A20 in B-cell lymphomas.
Kato M; Sanada M; Kato I; Sato Y; Takita J; Takeuchi K; Niwa A; Chen Y; Nakazaki K; Nomoto J; Asakura Y; Muto S; Tamura A; Iio M; Akatsuka Y; Hayashi Y; Mori H; Igarashi T; Kurokawa M; Chiba S; Mori S; Ishikawa Y; Okamoto K; Tobinai K; Nakagama H; Nakahata T; Yoshino T; Kobayashi Y; Ogawa S
Nature; 2009 Jun; 459(7247):712-6. PubMed ID: 19412163
[TBL] [Abstract][Full Text] [Related]
9. A20 and CYLD do not share significant overlapping functions during B cell development and activation.
Chu Y; Soberon V; Glockner L; Beyaert R; Massoumi R; van Loo G; Krappmann D; Schmidt-Supprian M
J Immunol; 2012 Nov; 189(9):4437-43. PubMed ID: 23002441
[TBL] [Abstract][Full Text] [Related]
10. Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20.
Turer EE; Tavares RM; Mortier E; Hitotsumatsu O; Advincula R; Lee B; Shifrin N; Malynn BA; Ma A
J Exp Med; 2008 Feb; 205(2):451-64. PubMed ID: 18268035
[TBL] [Abstract][Full Text] [Related]
11. The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis.
Onizawa M; Oshima S; Schulze-Topphoff U; Oses-Prieto JA; Lu T; Tavares R; Prodhomme T; Duong B; Whang MI; Advincula R; Agelidis A; Barrera J; Wu H; Burlingame A; Malynn BA; Zamvil SS; Ma A
Nat Immunol; 2015 Jun; 16(6):618-27. PubMed ID: 25939025
[TBL] [Abstract][Full Text] [Related]
12. Keratinocyte-specific ablation of the NF-κB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis.
Lippens S; Lefebvre S; Gilbert B; Sze M; Devos M; Verhelst K; Vereecke L; Mc Guire C; Guérin C; Vandenabeele P; Pasparakis M; Mikkola ML; Beyaert R; Declercq W; van Loo G
Cell Death Differ; 2011 Dec; 18(12):1845-53. PubMed ID: 21566665
[TBL] [Abstract][Full Text] [Related]
13. The ubiquitin editing enzyme A20 (TNFAIP3) is upregulated during permanent middle cerebral artery occlusion but does not influence disease outcome.
Mc Guire C; Rahman M; Schwaninger M; Beyaert R; van Loo G
Cell Death Dis; 2013 Mar; 4(3):e531. PubMed ID: 23470538
[No Abstract] [Full Text] [Related]
14. The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals.
Hitotsumatsu O; Ahmad RC; Tavares R; Wang M; Philpott D; Turer EE; Lee BL; Shiffin N; Advincula R; Malynn BA; Werts C; Ma A
Immunity; 2008 Mar; 28(3):381-90. PubMed ID: 18342009
[TBL] [Abstract][Full Text] [Related]
15. Deubiquitinating enzyme A20 negatively regulates NF-κB signaling in skeletal muscle in mdx mice.
Charan RA; Hanson R; Clemens PR
FASEB J; 2012 Feb; 26(2):587-95. PubMed ID: 22012122
[TBL] [Abstract][Full Text] [Related]
16. TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy.
Matsuzawa Y; Oshima S; Takahara M; Maeyashiki C; Nemoto Y; Kobayashi M; Nibe Y; Nozaki K; Nagaishi T; Okamoto R; Tsuchiya K; Nakamura T; Ma A; Watanabe M
Autophagy; 2015; 11(7):1052-62. PubMed ID: 26043155
[TBL] [Abstract][Full Text] [Related]
17. A20 Inhibits β-Cell Apoptosis by Multiple Mechanisms and Predicts Residual β-Cell Function in Type 1 Diabetes.
Fukaya M; Brorsson CA; Meyerovich K; Catrysse L; Delaroche D; Vanzela EC; Ortis F; Beyaert R; Nielsen LB; Andersen ML; Mortensen HB; Pociot F; van Loo G; Størling J; Cardozo AK
Mol Endocrinol; 2016 Jan; 30(1):48-61. PubMed ID: 26652732
[TBL] [Abstract][Full Text] [Related]
18. DNGR1-mediated deletion of A20/Tnfaip3 in dendritic cells alters T and B-cell homeostasis and promotes autoimmune liver pathology.
Das T; Bergen IM; Koudstaal T; van Hulst JAC; van Loo G; Boonstra A; Vanwolleghem T; Leung PSC; Gershwin ME; Hendriks RW; Kool M
J Autoimmun; 2019 Aug; 102():167-178. PubMed ID: 31151831
[TBL] [Abstract][Full Text] [Related]
19. Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and experimental colitis.
Vereecke L; Sze M; Mc Guire C; Rogiers B; Chu Y; Schmidt-Supprian M; Pasparakis M; Beyaert R; van Loo G
J Exp Med; 2010 Jul; 207(7):1513-23. PubMed ID: 20530205
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor-kappaB regulates beta-cell death: a critical role for A20 in beta-cell protection.
Liuwantara D; Elliot M; Smith MW; Yam AO; Walters SN; Marino E; McShea A; Grey ST
Diabetes; 2006 Sep; 55(9):2491-501. PubMed ID: 16936197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
